SAN DIEGO–(BUSINESS WIRE)—- $DFCO #Dalrada–Dalrada Corporation (OTCQB: DFCO, “Dalrada”) would like to provide an update to elaborate on the previously announced statement within the Q3 2021 filing, “Dalrada Health continues to explore additional products and services within the immunization and personal protective equipment industry”. Effectively addressing the current needs of the healthcare industry, clean energy, and technology, Dalrada’s first quarter 2022 (Quarter ending September 30, 2021) gross revenue